Back to User profile » Dr Keiji Hirai
Papers published by Dr Keiji Hirai:
Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients
Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y
International Journal of Nephrology and Renovascular Disease 2024, 17:135-149
Published Date: 17 May 2024
The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis
Yanai K, Hirai K, Kaneko S, Mutsuyoshi Y, Kitano T, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Drug Design, Development and Therapy 2023, 17:3233-3248
Published Date: 3 November 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
No Significant Changes of Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Kidney Disease by Switching from Linagliptin to Teneligliptin
Hirai K, Nonaka H, Ueda M, Morino J, Kaneko S, Minato S, Mutsuyoshi Y, Yanai K, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Pragmatic and Observational Research 2021, 12:81-91
Published Date: 6 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Factors Associated with the Change in Carotid Maximum Intima-Media Thickness in Patients with Moderate-to-Advanced Stage Chronic Kidney Disease
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2020, 13:3637-3643
Published Date: 12 October 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2020, 13:215-225
Published Date: 30 January 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Factors Associated with Uremic Pruritus in Patients Undergoing Peritoneal Dialysis
Minato S, Hirai K, Morino J, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Hoshino T, Ookawara S, Morishita Y
International Journal of Nephrology and Renovascular Disease 2020, 13:1-9
Published Date: 14 January 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk factors and utility of maximum carotid intima–media thickness as a surrogate marker for coronary artery stenosis
Hirai K, Imamura S, Hirai A, Misumi K, Ookawara S, Morishita Y
Therapeutics and Clinical Risk Management 2018, 14:1407-1416
Published Date: 13 August 2018